Back to Iris Pharma home page

Home  |  Contact  |  Sitemap    |  Restricted area  

Phase II - III

Iris Pharma is a leading, therapeutically specialized Contract Research Organization (CRO) focused on ophthalmology clinical trials.

 

Iris Pharma has managed partial or full-service phase II and phase III clinical trials in many eye disorders.

 

We maintain a network of highly motivated investigators for clinical research throughout Austria, Belgium, Denmark, Eastern Europe (Bulgaria, Czech Republic, Poland, Romania), Eire, France, Germany, India, Israel, Italy, Morocco, North America (USA, Canada), Portugal, Saudi Arabia, Spain, Switzerland, The Nertherlands, Tunisia, Turkey and the United Kingdom.

 

Iris Pharma's experience in the field of ophthalmology enables us to conduct phase 2 and phase 3 clinical trials which required specific knowledge, for exemple analysis of visual field or evaluation of inflammation by laser flare meter.

Add to favoritesPrintSend to a friend

Fields of expertise

• Glaucoma/Ocular hypertension
• Dry eye syndrome, Gougerot-Sjögren syndrome
• Retinal disorders (Age-related Macular Degeneration (AMD or ARMD))
• Diabetic retinopathy
• Eye socket disorders (infection, inflammation)
• Ocular allergy
• Cataract surgery (LASIK PRK)
• Conjunctival disorders (allergic conjunctivitis, keratoconjunctivitis sicca, trachoma)
• Orphan disease
• Medical devices
• Contactology
• Post surgical inflammation
• Ocular rosacea

» Back to the top

IRIS Pharma